Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for bronchiolitis obliterans syndrome after lung transplantation
2010-021983-14Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Bronchiolitis Obliterans Syndrome (BOS) and Bronchiolitis Obliterans (BO) comparing Montelukast with Placebo (2 arms). Primary endpoints: Survival/retransplantation rate at 1 year post-diagnosis of fBOS and Survival/retransplantation rate at 2 years post-diagnosis of fBOS. Started Sep 2010; status: completed.
02
Drugs
montelukast
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)Bronchiolitis Obliterans (BO)
Beyond the preview
Go deeper on 2010-021983-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021983-14.